Alzamend Neuro, Inc. logo

ALZNAlzamend Neuro, Inc.

ALZN Stock Price, Valuation & Chart | Alzamend Neuro, Inc.

Compare

ALZN Historical price chart

ALZN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization6.47M
PE Ratio-0.59
EPS-2.9
Trading Volume100.45K
Today's High/Low1.71/1.56
Dividend Yield0.00
52 Week High/Low2.68/0.84
Shares Outstanding3.80M
ALZN Financial Statement
ALZN Analyst ratings
ALZN Analysis & performance metrics

ALZN Company profile

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric…

ALZN Management team

Management
Kenneth S. Cragun CPA
Senior Vice President of Finance
Henry C. W. Nisser Esq.CTO
Executive Vice President, General Counsel & Director
David J. KatzoffCFO
Chief Financial Officer
Stephan JackmanCEO
Chief Executive Officer & Director
Milton Charles Ault III
Founder & Vice Chairman
Total 5 executives

ALZN Frequently asked questions

What is Alzamend Neuro, Inc. (ALZN) Stock Price?

Current stock price of Alzamend Neuro, Inc. (ALZN) stock is $1.700. The stock price is +3.86% higher in the session. The intraday range can be seen from this page. Volume of Alzamend Neuro, Inc. (ALZN) stock is 100.45K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Alzamend Neuro, Inc. (ALZN) stock price going up or down today?

The stock price of Alzamend Neuro, Inc. (ALZN) can change with earnings, company news, and overall market sentiment. Alzamend Neuro, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Alzamend Neuro, Inc. stock expensive at its current price?

Whether Alzamend Neuro, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ALZN on this page is -0.59. EPS on this page is -2.90. Compare those figures with peers and growth expectations before deciding if the current Alzamend Neuro, Inc. price is justified.

How has the stock price of Alzamend Neuro, Inc. (ALZN) performed historically?

Historical performance for Alzamend Neuro, Inc. (ALZN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ALZN reacted to past earnings and market events.

Should I buy Alzamend Neuro, Inc. (ALZN) stock, at this price?

Buying Alzamend Neuro, Inc. (ALZN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.